Acetylcholinesterase Inhibitor Prescribed/Recommended for Persons Diagnosed With Mild to Moderate Alzheimer's Disease

Identifying Attributes

Care Settings
Dementia Care
Country
Australia
Publishing Organisation
Australian Dementia Network (ADNeT) Registry
Type of Quality Indicator
Process
IOM Quality Dimension
Effectiveness
Domain
Interventions to Promote Cognition, Independence and Wellbeing

Defining Attributes

Definition

Proportion of patients who are diagnosed with mild to moderate Alzheimer's disease and have acetylcholinesterase inhibitor (AChEI) prescribed/recommended.

Numerator

Number of patients who are diagnosed with mild to moderate Alzheimer's disease and have acetylcholinesterase inhibitor (AChEI)prescribed/recommended.

Denominator

Number of patients diagnosed with mild to moderate Alzheimer's disease.

Exclusions
Use of Risk Adjustment
No
Risk Adjustments

None

Stratifications

85 years and under, over 85 years.

Data Attributes

Type of Data Collection
Standardised clinical data
Data Collection Methods

Data entered by participating sites into a secure online platform.

Frequency of Data Collection
Continuous
Frequency of Data Collection in Days
1
Reporting Methods

Yearly public report, six-monthly site reports, real time data via secure platform for sites.

Reporting Frequency
Annually (public), biannually and real time (available to site only)
Reporting Frequency in Days
1-365
Indicator Has Recommended Targets
No

Source and Reference Attributes

Evidence Source

Ward SA, Brodaty H, Lin X, Wallis K, Honardoost MA, Tsui A, Lassetter C, Rowe C, Anstey K, Brodtmann A, Chong T, Darling G, Inacio M, Jeon Y-H, Kain B, Loi S, McCabe M, Naismith S, Natarajan K, Nelson M, Newton L, Pietsch A, Quirke L, Rand E, Yates M, Arsenova V, Earnest A, McAloney K, Pourghaderi AR, Rahja M, Richardson J, Tan S and Ahern S. The Australian Dementia Network (ADNeT) Registry 2022 Annual Report. Monash University, School of Public Health and Preventive Medicine, May 2023.

Technical Specifications

Not publicly available.

Link to Measurement Tools
Quality Indicator Confirmed to be Part of a Program Used to Monitor Quality and Safety of Care Among Older People at a Population-Level between 2012-2022
Yes
Assessed by the Australian Consortium for Aged Care Collaborators as Generally Containing Good Properties (Importance and Scientific Acceptability)
No
Australian Consortium for Aged Care Endorsed
No
Identified by PHARMA-Care Project
No
Upload Date
12 March 2025